← All stocks

ANAPTYSBIO, INC

ANAB No buying or selling

CIK 0001370053 #2173 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

40.3×

Daniel Faga holds 40.3 times base salary in stock. $28.47M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $57.40, the price Common Stock was last bought or sold at on the open market here, on 30 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

EcoR1 Capital, LLC entity

Director

—

7,880,094

27.08%

$452.31M

+1.1%

Faga Daniel

President, CEO

—

495,965

1.70%

$28.47M

+22.3%

Lizzul Paul F.

Chief Medical Officer

—

42,088

0.1446%

$2.42M

+149.6%

Schmid John P.

Director

—

37,652

0.1294%

$2.16M

+865.4%

MULROY DENNIS

CHIEF FINANCIAL OFFICER

—

21,852

0.0751%

$1.25M

+210.0%

Orwin John A

Director

—

17,995

0.0618%

$1.03M

+439.6%

LOUMEAU ERIC J

CHIEF LEGAL OFFICER

—

12,835

0.0441%

$736.71K

+172.7%

Jain Rita

Director

—

11,864

0.0408%

$680.98K

+161.7%

RENTON HOLLINGS

Director

—

10,995

0.0378%

$631.10K

+463.8%

Marquet Magda

Director

—

9,930

0.0341%

$569.97K

+154.6%

Ware J. Anthony

Director

—

9,630

0.0331%

$552.75K

+28.4%

FENTON DENNIS M

Director

—

4,965

0.0171%

$284.99K

+154.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,300

History held since 31 Jan 2017